Tagged with Daewoong

Brazil Pharma News: Biophytis/Innovation Solutions Partnership; Eurofarma’s Major Biotech Investment

Brazil Brazil Pharma News: Biophytis/Innovation Solutions Partnership; Eurofarma’s Major Biotech Investment

Brazil The latest pharma news from Brazil, including the partnership between Biophytis and Innovation Solutions Pharma; Merck’s 100 years in Brazil; Eurofarma’s USD 100 million biotech investment, and GSK’s green light from ANVISA. Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos in Brazil…

China Pharma News: Approval of 2 Domestic COVID-19 Treatments; Roche/CARsgen Partnership; Takeda Colorectal Cancer Deal

China China Pharma News: Approval of 2 Domestic COVID-19 Treatments; Roche/CARsgen Partnership; Takeda Colorectal Cancer Deal

China A roundup of some of the biggest pharma and biotech news from China including the approval of two domestically developed COVID treatments; Daewoong’s idiopathic pulmonary fibrosis licensing deal, Roche’s gastric cancer partnership with CARsgen; Sino Biopharm’s continued attempt to buyout of F-star Therapeutics and Takeda’s deal with Hutchmed for a…

Korea pharma news: SK Bioscience’s COVID-19 vaccine, Daewoong’s partnership with AstraZeneca Korea, Vivozon production halt …

South Korea Korea pharma news: SK Bioscience’s COVID-19 vaccine, Daewoong’s partnership with AstraZeneca Korea, Vivozon production halt …

South Korea The latest healthcare and pharma news from South Korea, including SK Bioscience’s COVID-19 vaccine, Daewoong’s partnership with AstraZeneca Korea and UCI Therapeutics, Vivozon production halt and GC’s acquistion of US-based CDMO, BioCentriq. SK Bioscience’s COVID-19 vaccine to be tested against Omicron (Korea Biomedical Review) SK Bioscience’s has submitted a biologics…

Daewoong Pharmaceutical: Record Sales and 100 Billion Won R&D Investment

Korea Daewoong Pharmaceutical: Record Sales and 100 Billion Won R&D Investment

Korea South Korean heavyweight Daewoong Pharmaceutical saw record sales in 2018, but did see a decrease in its EBITDA figures. To ensure its future profitability, the company has decided to invest heavily in the research of development of new drugs, with a new 100 billion won facility planned. Daewoong Pharmaceutical’s…

Byung Guk Yang – CEO, Daewoong Bio, South Korea

Korea Byung Guk Yang – CEO, Daewoong Bio, South Korea

Korea Dr Byung Guk Yang, CEO of Daewoong Bio, explains the challenges the Korean healthcare system is facing and how his experience in the public sector now helps him lead a private sector company. He also offers his insights into Daewoong Bio’s diversified business model and highlights the need for internationalization.…

Daewoong Pharmaceutical Interview with Jong-Wook Lee, CEO, Daewoong Pharmaceutical

Daewoong Pharmaceutical What are the main milestones and achievements of Daewoong’s pharmaceutical business over its decades of evolution? Daewoong was first established in 1945 as Chosun Liver-oil Pharmaceutical Industry Co., Ltd. The company name was later changed to Daehan Vitamin in 1961, and again to the current name, Daewoong Pharmaceutical in 1978.…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page